Kategori: Publikationer

2016-02-25

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K. Ann Rheum Dis. 2016 Feb;75(2):356-61.

2016-02-24

Spinal Mobility in Axial Spondyloarthritis: A Cross-Sectional Clinical Study.

Mogard E, Lindqvist E, Bergman S, Bremander A.

Musculoskeletal Care. 2017 Mar;15(1):36-48. doi: 10.1002/msc.1138. Epub 2016 Feb 24.

PMID: 26916253

2016-01-28

MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.

Forslind K, Svensson B. Scand J Rheumatol. 2016;45(2):99-102.

2016-01-14

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou K, Turesson C, Teleman A, Knight A, Lindqvist E, Larsson P, Cöster L, Forslind K, van Vollenhoven R, Heimbürger M. RMD Open. 2016 Jan 14;2(1):e000133.

2016-01-12

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.PMID: 26757747

2015-11-27

Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.

van Vollenhoven RF, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Sasso EH, Hwang CC, Segurado OG, Geborek P. Arthritis Rheumatol. 2015 Nov;67(11):2855-60.

2015-11-16

A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial.

Larsson I, Fridlund B, Arvidsson B, Teleman A, Svedberg P, Bergman S.

BMC Musculoskelet Disord. 2015 Nov 16;16:354. doi: 10.1186/s12891-015-0817-6.

PMID: 26573936

2015-08-27

Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.

de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ospelt C, Svensson B, van der Helm-van Mil AH. J Rheumatol. 2015 Aug;42(8):1383-91.

2015-08-25

Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.

Saevarsdottir S, Rezaei H, Geborek P, Petersson I, Ernestam S, Albertsson K, Forslind K, van Vollenhoven RF; SWEFOT study group. Ann Rheum Dis. 2015 Aug;74(8):1509-14.

2015-06-25

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF. Ann Rheum Dis. 2015 Jun;74(6):1102-9.

« Äldre Inlägg

Nyare Inlägg »

Cookie-samtycke med Real Cookie Banner

Kategori: Publikationer

Adress

Kontakt